Historically, lower molecular weight (LMW) AR variants have been reported in studies on AR in androgen insensitivity syndrome and in malignancies, but their role in PCa was established only about a decade ago [32,33,34,35,36]. Here, AR is linked to androgen insensitivity syndrome.